Larvol Delta - Randomised-clinical-trial-efficacy-and-safety-of-the-live-biotherapeutic-product-MRx1234-in-patients-with-irritable-bowel-syndrome

Blautix (MRx1234) - 4D Pharma

http://www.ncbi.nlm.nih.gov/pubmed/36369645

Nov 15, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next